Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

New matrix metalloproteinase inhibitors show potential in arthritis

Feb. 1, 2001

Antiinflammatory compounds in development at Abbott inhibit adhesion molecules

Jan. 31, 2001

Increased ACR20 response rate reported with 5G1.1

Jan. 30, 2001

MMP-13 inhibitors particularly useful for arthritis, atherosclerosis, as claimed by AstraZeneca

Jan. 29, 2001

Canadian company describes new hexapeptides acting as CCR3 receptor antagonists

Jan. 26, 2001

Cypress Bioscience and Fresenius restructure Prosorba agreement

Jan. 26, 2001

Scios completes preliminary clinical trial of SCIO-469, its p38 kinase inhibitor

Jan. 26, 2001

Recent Japanese patent covers naturally occurring antiinflammatory agents

Jan. 24, 2001

NicOx's HCT-3012 moves into phase II clinical trials in Europe and the U.S.

Jan. 24, 2001

Pyrazines acting as inhibitors of cell adhesion molecule expression

Jan. 23, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
Empire Discovery Institute, Univ. of Rochester identify IRAK inhibitors
BioWorld Science
Empire Discovery Institute and the University of Rochester have discovered new interleukin-1 receptor-associated kinase 1 (IRAK-1) and/or IRAK-4 inhibitors...